You are here

Home

Global

In depth: How the ‘deep state’ scientists vilified by Trump helped develop vaccines in record time

Tue, 2020-12-15 17:58 — mike kraft
How the ‘deep state’ scientists vilified by Trump helped him deliver an unprecedented achievement A $14-billion partnership between government and industry is spurring the quickest vaccine development in U.S. history. Yasmeen Abutaleb, Laurie McGinley, Carolyn Y. Johnson Washington Post

....

Country / Region Tags: 
Germany
Global
United States
General Topic Tags: 
COVID-19
Capacity
Contagion
Disease
Government
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

FDA Authorizes 1st Home Coronavirus Test That Doesn't Require A Prescription

Tue, 2020-12-15 17:06 — mike kraft

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-antigen-test-first-over-counter-fully-home-diagnostic

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Health
Pandemics
Science
Technology
Problem, Solution, SitRep, or ?: 
Situation Report

STUDY: Feasibility of continuous fever monitoring using wearable devices

Tue, 2020-12-15 10:32 — mike kraft
Feasibility of continuous fever monitoring using wearable devices Elevated core temperature constitutes an important biomarker for COVID-19 infection; however, no standards currently exist to monitor fever using wearable peripheral temperature sensors. Evidence that sensors could be used to develop fever monitoring capabilities would enable large-scale health-monitoring research and provide high-temporal resolution data on fever responses across heterogeneous populations. We launched the TemPredict study in March of 2020 to capture continuous physiological data, including peripheral temperature, from a commercially available wearable device during the novel coronavirus pandemic. We coupled these data with symptom reports and COVID-19 diagnosis data.
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

Poor countries face long wait for vaccines despite promises

Tue, 2020-12-15 10:17 — mike kraft
Poor countries face long wait for vaccines despite promises NEW DELHI (AP) — With Americans, Britons and Canadians rolling up their sleeves to receive coronavirus vaccines, the route out of the pandemic now seems clear to many in the West, even if the... AP NEWS
Country / Region Tags: 
Africa
Global
India
Philippines
SouthEast Asia
United Nations
General Topic Tags: 
COVID-19
Contagion
Disease
Pandemics
Scarcity
Problem, Solution, SitRep, or ?: 
Situation Report

A guide to who can safely get the Pfizer/BioNTech Covid-19 vaccine

Tue, 2020-12-15 09:30 — mike kraft
A guide to who can safely get the Pfizer/BioNTech Covid-19 vaccine Expect answers to evolve as the vaccines go into broader use. But here’s what is known so far, and what experts recommend. Helen Branswell STAT

WIth the first doses of Covid-19 vaccine being administered across the United States, questions abound about who can safely get them.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Complexity
Contagion
Demographics
Disease
Health
Pandemics
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis

Health FDA review clears path for second coronavirus vaccine, this one developed by Moderna

Tue, 2020-12-15 09:08 — mike kraft
FDA review clears path for second coronavirus vaccine, this one developed by Moderna The data review showed the vaccine was 94 percent effective and had no serious side effects. Carolyn Y. Johnson Washington Post
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Government
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Situation Report

After 110K virus deaths, nursing homes face vaccine fears

Mon, 2020-12-14 09:31 — mike kraft
After 110K virus deaths, nursing homes face vaccine fears After 110,000 deaths ravaged the nation’s nursing homes and pushed them to the front of the vaccine line, they now face a vexing problem: Skeptical residents and workers balking at getting the... AP NEWS

After 110,000 deaths ravaged the nation’s nursing homes and pushed them to the front of the vaccine line, they now face a vexing problem: Skeptical residents and workers balking at getting the shots.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Communication
Contagion
Demographics
Disease
Government
Health
Pandemics
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Roundup: Top health official warns pandemic "could go on and on" if not enough people are vaccinated

Mon, 2020-12-14 09:21 — mike kraft
Top health official warns pandemic "could go on and on" if not enough people are vaccinated Dr. Francis Collins, director of the US National Institutes of Health, has warned that the pandemic could drag on if not enough people get vaccinated. By <a href="/profiles/jessie-yeung">Jessie Yeung</a>, Adam Renton, Emma Reynolds, Ed Upright, Melissa Macaya and <a href="/profiles/meg-wagner">Meg Wagner</a>, CNN CNN
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Government
Pandemics
Policy
Problem, Solution, SitRep, or ?: 
Situation Report

Most Americans with allergies should be safe to get Pfizer-BioNTech vaccine: FDA

Sun, 2020-12-13 10:47 — mike kraft
Most Americans with allergies should be safe to get Pfizer-BioNTech vaccine: FDA Top U.S. Food and Drug Administration regulators said on Saturday that most Americans with allergies should be safe to receive the COVID-19 vaccine developed by Pfizer Inc and Germany's Biotech SE. Michael Erman U.S.
Country / Region Tags: 
Germany
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Health
Pandemics
Science
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

With U.S. now in hand, BioNTech CEO looks for more vaccine production

Sat, 2020-12-12 10:18 — mike kraft
With U.S. now in hand, BioNTech CEO looks for more vaccine production The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up manufacturing to meet huge demand. Michael Erman U.S.
Country / Region Tags: 
Germany
Global
United States
General Topic Tags: 
COVID-19
Capacity
Contagion
Disease
Government
Health
Pandemics
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Global
howdy folks
Page loaded in 2.011 seconds.